themoneynarrative Viemed Healthcare (VMD.TO)/Protech Home Medical (PTQ.V) update

These companies have evolved considerably from the days of Patient Home Monitoring (previously PHM.V), which themoneynarrative readers will know if they have been following the story.  On November 13, 2017 we recommended that investors buy PHM.V under $0.30, telling readers that

themoneynarrative 3-month report card – Patient Home Monitoring (PHM.V)/Viemed Healthcare (VMD.V)

Report publication date: November 13, 2017
Recommendation: Buy under $0.30.
Prior trading day (November 10, 2017) price close: $0.295
Report date (November 13, 2017) trading range: $0.28 – $0.30

Patient Home Monitoring (PHM.V) – an update

Themoneynarrative recommended that investors buy PHM.V under $0.30 on November 13, 2017.  Our PHM.V report card published on December 13, 2017 confirmed a 12.5% gain in the share price over the prior month.

themoneynarrative report card – Patient Home Monitoring (PHM.V)

Report publication date: November 13, 2017
Recommendation: Buy under $0.30.
Prior trading day (November 10, 2017) price close: $0.295
Report date (November 13, 2017) trading range: $0.28 – $0.30

Patient Home Monitoring (PHM.V)

A themoneynarrative reader recently asked about PHM.V.  This is a company that we have been following for many years, which had a real roller coaster share price from mid-2014 to mid-2016, moving from $0.22 to a high of $2.01 and back to $0.15.  While the price is a little better today, at $0.295, PHM.V has not (yet?) regained its former lustre.